New-Onset Rheumatic Immune-Mediated Inflammatory Diseases Following SARS-CoV-2 Vaccinations until May 2023: A Systematic Review

A comprehensive, up-to-date systematic review (SR) of the new-onset rheumatic immune-mediated inflammatory diseases (R-IMIDs) following COVID-19 vaccinations is lacking. Therefore, we investigated the demographics, management, and prognosis of new R-IMIDs in adults following SARS-CoV-2 vaccinations....

Descripción completa

Detalles Bibliográficos
Autores principales: Nune, Arvind, Durkowski, Victor, Pillay, S. Sujitha, Barman, Bhupen, Elwell, Helen, Bora, Kaustubh, Bilgrami, Syed, Mahmood, Sajid, Babajan, Nasarulla, Venkatachalam, Srinivasan, Ottewell, Lesley, Manzo, Ciro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10610967/
https://www.ncbi.nlm.nih.gov/pubmed/37896974
http://dx.doi.org/10.3390/vaccines11101571

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10610967/
https://www.ncbi.nlm.nih.gov/pubmed/37896974
http://dx.doi.org/10.3390/vaccines11101571

Ejemplares similares